Rubius Therapeutics
Rubius Therapeutics is a biotechnology company using stem cells to develop red blood cell cellular therapies.
4
Funding Rounds
$365.0m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| No**** Af**** | - | - | linkedin twitter |
| Name | Phone | Social networks | |
|---|---|---|---|
| No**** Af**** | - | - | linkedin twitter |
| Jo****** Sy***** | - | - | - |
| Mi***** Ro******** | - | - | |
| An** Pr**** | - | - | - |
| Da*** R. Ep***** | - | - | - |
| Ca******* An**** So** | - | - | - |
| Pa*** Ca***** | - | - | |
| Fr***** Cu** | - | - | - |
| Na***** Ho**** | - | - | - |
Funding series
Funding Series Analysis
The company Rubius Therapeutics has raised a total of $120m in funding over 4 rounds.
Key Insights:
- Rubuis Therapeutics , June 2017: $120m
- Rubius Therapeutics funding round, March 2018: $100m
- Rubius Therapeutics funding round, June 2017: $120m
- Rubius Therapeutics Series A round, December 2015: $25m
Rubuis Therapeutics , June 2017
$120m
Rubius Therapeutics funding round, March 2018
$100m
Rubius Therapeutics funding round, June 2017
$120m
Rubius Therapeutics Series A round, December 2015
$25m
Industries
Rubius Therapeutics is active in the following industries:
- Healthcare
- Biotechnology
- Internal medicine
- Cell therapy
- Cancer immunotherapy
- Engineering
- Stem cell technology
- Immunotherapy
- Technology
- Medicine
- Regenerative medicine
- Biomedical engineering
- Therapeutics
- Autoimmune disease
- Biopharmaceutical
- Biology
- Oncology
- Cancer